Published in J Exp Med on June 01, 1976
Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med (1977) 1.73
Immunological unresponsiveness to thymus-independent antigens: two fundamentally different genetic mechanisms of B-cell unresponsiveness to dextran. J Exp Med (1977) 1.50
Characterization of self-reactive B cells by polyclonal B-cell activators. J Exp Med (1977) 1.34
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure. Infect Immun (1979) 1.24
Solubilization of quantum dots with a recombinant peptide from Escherichia coli. Small (2007) 1.07
Induction of immunological tolerance requires that the B cells can respond to the polyclonal B-cell-activating properties of the thymus-independent antigens. J Exp Med (1977) 1.06
Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proc Natl Acad Sci U S A (1990) 1.01
Evidence for the existence of self-reactive human B lymphocytes. Clin Exp Immunol (1977) 0.94
Regulatory mechanism of autoantibody production in mice to bromelin-treated isologous red blood cells. Immunology (1979) 0.87
Cellular basis of persistent tolerance induced by an aggregate free heterologous immunoglobulin. Immunology (1977) 0.81
B-cell subsets responsive to fluorescein-conjugated antigens. III. Differential effect of E. Coli lipopolysaccharide on T-dependent and T-independent responses in vivo. Immunology (1979) 0.81
The adoptive secondary response to human serum albumin under conditions of high antigen pressure. The response of high and low avidity B cell subsets. Immunology (1977) 0.77
Production of an antibody-like factor in the sea star Asterias rubens: involvement of at least three cellular populations. Immunology (1986) 0.75
Plaque Formation in Agar by Single Antibody-Producing Cells. Science (1963) 10.20
Immunization of normal mouse spleen cell suspensions in vitro. Science (1966) 6.47
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
FLUORESCEIN DIACETATE AS A REFERENCE COLOR STANDARD IN FLUORESCENT ANTIBODY STUDIES. Anal Biochem (1964) 2.74
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
TOLERANCE TO A PROTEIN ANTIGEN IN ADULT MICE AND THE EFFECT OF NONSPECIFIC FACTORS. J Immunol (1963) 2.31
Immune response to a hapten coupled to a nonimmunogenic carrier. Influence of lipopolysaccharide. J Exp Med (1972) 1.95
Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens. J Exp Med (1974) 1.75
Cellular events during induction of immunologic unresponsiveness in adult mice. J Immunol (1971) 1.72
The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters. J Exp Med (1973) 1.49
Studies on the induction of immunologic unresponsiveness. I. Effects of endotoxin and phytochemagglutinin. J Immunol (1967) 1.47
Effect of immunological unresponsiveness on different cell populations. Transplant Rev (1972) 1.45
Rapid breaking of tolerance against Escherichia coli lipopolysaccharide in vivo and in vitro. J Exp Med (1972) 1.40
The tolerant cell: direct evidence for receptor blockade by tolerogen. J Immunol (1974) 1.35
In vitro induction of specific immune responses in the absence of serum: requirement for nonspecific T or B cell mitogens. Eur J Immunol (1973) 1.32
Hapten-induced B cell paralysis. II. Evidence for trivial mechanisms of tolerance. Eur J Immunol (1976) 0.96
Cellular events in tolerance. IV. The effect of a graft-versus-host reaction and endotoxin on hapten- and carrier-specific tolerance. Eur J Immunol (1974) 0.96
Mechanism of b-lymphocyte activation: failure to obtain evidence of a direct role of the Ig receptors in the triggering process. Scand J Immunol (1975) 0.95
Failure of lymphocytes to reexpress antigen receptors after brief interaction with a tolerogenic D-amino acid copolymer. Proc Natl Acad Sci U S A (1974) 0.94
Hapten-induced paralysis. I. Evidence for the persistence of hapten-specific immunocompetent B lymphocytes in specifically paralyzed mice. Eur J Immunol (1974) 0.93
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol (1976) 9.11
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39
Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res (1997) 6.37
Regulatory effect of antibody on the immune response. Adv Immunol (1968) 6.03
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
An integrated computational pipeline and database to support whole-genome sequence annotation. Genome Biol (2002) 5.24
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Two distinct factors are required for induction of T-cell growth. Nature (1980) 4.13
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet (2005) 3.97
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem (2001) 3.69
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev (1990) 3.50
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27
The role of mitogenic lectins in T-cell triggering. Nature (1979) 3.26
Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte. Cell (1977) 3.23
Second generation immune networks. Immunol Today (1991) 2.97
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Private health care in developing countries. BMJ (2001) 2.89
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84
Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry (2005) 2.78
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut (2003) 2.74
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages. J Exp Med (1977) 2.68
Cognitive deficits in the early stages of Parkinson's disease. Brain (1983) 2.65
Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur J Immunol (1979) 2.59
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
Preventing child abuse and neglect with a program of nurse home visitation: the limiting effects of domestic violence. JAMA (2000) 2.50
Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta. Proc Natl Acad Sci U S A (1991) 2.46
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet (1995) 2.43
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Frequency of antigen-sensitive cells to thymus-independent antigens. Cell Immunol (1971) 2.39
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol (1989) 2.35
IgG subclasses in bacterial infections. Monogr Allergy (1986) 2.32
Specific T helper cells that activate B cells polyclonally. In vitro enrichment and cooperative function. J Exp Med (1980) 2.27
Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med (1990) 2.23
Selective triggering of B cell subpopulations by mitogens. Eur J Immunol (1974) 2.22
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
Functional analysis of B cell heterogeneity. Transplant Rev (1975) 2.17
High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17
19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro. Nature (1965) 2.12
Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors. Eur J Immunol (1979) 2.10
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res (1986) 2.04
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol (1969) 2.03
A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med (2000) 2.01
Prevalence of psychiatric disorders among persons convicted of driving while impaired. Arch Gen Psychiatry (2001) 1.93
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol (1972) 1.93
Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol (1988) 1.92
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood (2000) 1.90
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology (2007) 1.90
Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg (1994) 1.90
Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am J Hum Genet (1998) 1.87
Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87
Persistence of immunogenicity of two complex antigens retained in vivo. Immunology (1968) 1.87
Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res (2001) 1.85
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur J Immunol (1977) 1.83
Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature (1976) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol (1990) 1.82
Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature (1993) 1.82
Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol (1994) 1.81
Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices (2009) 1.81
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol (1984) 1.79
Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immun (1983) 1.78
Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem (1984) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol (2008) 1.73
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol Cell Biol (2000) 1.73
Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet (1991) 1.72